Are you Dr. Kendrick?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 64 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2501 N Orange Ave
Suite 800
Orlando, FL 32804Phone+1 407-303-2422Fax+1 407-303-2435
Summary
- Dr. James Kendrick IV, MD is an obstetrician/gynecologist in Orlando, Florida. He is currently licensed to practice medicine in Florida and Alabama. He is affiliated with AdventHealth Orlando.
Education & Training
University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 2002 - 2006
University of Alabama School of MedicineClass of 2002- University of Alabama Medical CenterFellowship, Gynecologic Oncology
Certifications & Licensure
FL State Medical License 2009 - 2025
AL State Medical License 2004 - 2009- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsPhase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent ...Vicky Makker, Virginia L. Filiaci, Lee-may Chen, Christopher J. Darus, James E. Kendrick
Gynecologic Oncology. 2015-07-01 - 110 citationsPhase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group studyEdwin A. Alvarez, William E. Brady, Joan L. Walker, Jacob Rotmensch, Xun C. Zhou
Gynecologic Oncology. 2012-03-01 - 29 citationsPatterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.Charles A. Leath, T. Michael Numnum, James E. Kendrick, Peter J. Frederick, Rodney P. Rocconi
International Journal of Gynecological Cancer. 2009-07-01
